| Comprehensive molecular portraits of human breast tumours Cancer Genome Atlas Network Nature 490 (7418), 61, 2012 | 5911 | 2012 |
| Comprehensive molecular characterization of human colon and rectal cancer Cancer Genome Atlas Network Nature 487 (7407), 330, 2012 | 3939 | 2012 |
| Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 3919 | 2011 |
| The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KRM Shaw, BA Ozenberger, ... Nature genetics 45 (10), 1113, 2013 | 2626 | 2013 |
| Comprehensive genomic characterization of squamous cell lung cancers Cancer Genome Atlas Research Network Nature 489 (7417), 519, 2012 | 2164 | 2012 |
| Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 | 1957 | 2014 |
| Comprehensive molecular characterization of clear cell renal cell carcinoma CGAR Network Nature 499 (7456), 43, 2013 | 1459 | 2013 |
| Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 1403 | 2014 |
| Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ... Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009 | 1180 | 2009 |
| A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene J Luo, MJ Emanuele, D Li, CJ Creighton, MR Schlabach, TF Westbrook, ... Cell 137 (5), 835-848, 2009 | 912 | 2009 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 887 | 2014 |
| Widespread deregulation of microRNA expression in human prostate cancer M Ozen, CJ Creighton, M Ozdemir, M Ittmann Oncogene 27 (12), 1788, 2008 | 733 | 2008 |
| Comprehensive molecular characterization of papillary renal-cell carcinoma Cancer Genome Atlas Research Network New England Journal of Medicine 374 (2), 135-145, 2016 | 505 | 2016 |
| Mining gene expression databases for association rules C Creighton, S Hanash Bioinformatics 19 (1), 79-86, 2003 | 478 | 2003 |
| Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function S Massarweh, CK Osborne, CJ Creighton, L Qin, A Tsimelzon, S Huang, ... Cancer research 68 (3), 826-833, 2008 | 459 | 2008 |
| The somatic genomic landscape of chromophobe renal cell carcinoma CF Davis, CJ Ricketts, M Wang, L Yang, AD Cherniack, H Shen, C Buhay, ... Cancer cell 26 (3), 319-330, 2014 | 451 | 2014 |
| Comprehensive and integrative genomic characterization of hepatocellular carcinoma A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ... Cell 169 (7), 1327-1341. e23, 2017 | 429 | 2017 |
| Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression DL Gibbons, W Lin, CJ Creighton, ZH Rizvi, PA Gregory, GJ Goodall, ... Genes & development 23 (18), 2140-2151, 2009 | 423 | 2009 |
| TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs X Su, D Chakravarti, MS Cho, L Liu, YJ Gi, YL Lin, ML Leung, A El-Naggar, ... Nature 467 (7318), 986, 2010 | 397 | 2010 |
| Prognostically relevant gene signatures of high-grade serous ovarian carcinoma RGW Verhaak, P Tamayo, JY Yang, D Hubbard, H Zhang, CJ Creighton, ... The Journal of clinical investigation 123 (1), 2012 | 385 | 2012 |
